Spok Holdings, Inc.

NASDAQ:SPOK

Medical - Healthcare Information Services

Healthcare
$10.93 +1.60%

+$0.17 today

Market cap
$228.30M
Beta
0.44
P/E (TTM)
17.2
EPS (TTM)
$0.61
Dividend yield
11.93%
52W Low $9.95High $19.31

Volume 0.18M

Average 0.17M

SPOK EBITDA

Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.

Spok Holdings, Inc.NASDAQ: SPOK

EBITDA · Q1 FY2026 · quarter ended Mar 2026

EBITDA declines year over year

Q1 FY2026 EBITDA of $3.62M fell 49.2% year over year, behind the -11.4% change in trailing-twelve-month EBITDA. Sequentially, it fell 28.8% from the prior quarter. Over 3 fiscal years it compounded at +75.9% a year.

Context

  • EBITDA amounted to 17.8% of revenue in FY2025, up 0.2 pp from a year earlier.
  • EBITDA increased in 2 of the last 3 fiscal years.

What to watch

Whether EBITDA reaches the consensus estimate from 1 analysts of $21.29M (-14.4%) for the fiscal year ending Dec 2026, a slowdown from the +2.7% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
$3.62M-28.8% QoQ
Last fiscal yearDec 2025
$24.87M+2.7% YoY
LTMMar 2026
$22.22M-11.4% YoY
EBITDA past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-49.2%-32.2%+17.0 pp
1 year+2.7%-14.4%-17.1 pp
3-year CAGR+75.9%——
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA history

USD · from the income statement

Latest · FY2025
24.87M USD
Year-over-year change
+2.7%
Reported Analyst consensus estimate

EBITDA vs competitors

How SPOK compares with its peers on the latest reported figures

  • Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -11.4% is the 7th highest of 11, against a peer median of +5.0%.
  • EBITDA amounts to 16.3% of revenue for SPOK, versus a peer median of 20.8%.
SPOK Competitors
EBITDA for SPOK and competitors
Company Period LTM YoY 3-year CAGR% of revenue
VMDViemed Healthcare, Inc.LTM Mar 2026$53.03M USD+28.1%+27.6%18.5%
TBRGTruBridge, Inc.LTM Mar 2026$32.57M USD-26.5%-3.8%9.4%
NRCNational Research CorporationLTM Mar 2026$27.87M USD-32.4%-15.0%20.1%
SPOKSpok Holdings, Inc.LTM Mar 2026$22.22M USD-11.4%+75.9%16.3%
SLPSimulations Plus, Inc.LTM Feb 2026$17.31M USD+4.6%-7.7%21.5%
DHDefinitive Healthcare Corp.LTM Mar 2026$11.6M USD+101.6%—4.9%
CERSCerus CorporationLTM Mar 2026$1.19M USD+114.0%—0.5%
MASS908 Devices Inc.LTM Mar 2026-$26.57M USD+5.3%—46.0%
SOPHSOPHiA GENETICS S.A.LTM Mar 2026-$66.08M USD-31.0%—81.4%
SENSSenseonics Holdings, Inc.LTM Mar 2026-$80.8M USD-25.3%—198.5%
CGCCanopy Growth CorporationLTM Mar 2026-CA$205.34M CAD+57.2%—65.7%
Peer median (excluding SPOK) —+5.0%-5.8%20.8%

Competitors are the stored peer set for SPOK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue142.15M134.53M139.03M137.65M139.71M
Cost of Revenue72.27M59.25M57.16M28.43M29.57M
Gross Profit69.89M75.28M81.87M109.22M110.14M
Gross Margin49.2%56.0%58.9%79.3%78.8%
Research & Development17.92M13.63M10.55M11.55M12.09M
Selling, General & Admin64.02M54.09M49.52M49.15M50.87M
Operating Expenses81.94M67.72M60.07M90.26M90.43M
Depreciation & Amortization10.45M3.57M4.5M4.15M3.43M
EBITDA(16.89M)4.57M26.82M24.22M24.87M
EBITDA Margin-11.9%3.4%19.3%17.6%17.8%
Operating Income(12.06M)7.57M21.8M18.97M19.71M
Operating Margin-8.5%5.6%15.7%13.8%14.1%
Interest Income320K592K1.1M1.15M820K
Interest Expense00000
Other Income / Expenses(15.28M)(6.57M)524K1.07M1.73M
Income Before Tax(27.33M)997K22.33M20.03M21.44M
Pre-Tax Margin-19.2%0.7%16.1%14.6%15.3%
Income Tax Expense(5.15M)(20.86M)6.66M5.07M5.56M
Net Income(22.18M)21.86M15.67M14.97M15.88M
Net Margin-15.6%16.2%11.3%10.9%11.4%
EPS (Basic)(1.14)1.110.790.740.77
EPS (Diluted)(1.14)1.090.770.730.75
Weighted Avg Shares19.4M19.67M19.95M20.24M20.61M
Weighted Avg Shares (Diluted)19.4M19.99M20.34M20.57M21.07M

Spok Holdings, Inc.

NASDAQ:SPOK

Intrinsic Alpha fair value

Locked

Current Price

$10.93

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.